21.11.2018 Views

U#3888_MH_ResearchReport (S)

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Monash Health<br />

Message from the Chair of the Board<br />

and the Chief Executive<br />

We are delighted to present the 2017 Monash Health Translational Precinct (<strong>MH</strong>TP)<br />

Research Report. The report highlights the outstanding achievements of Monash<br />

Health’s researchers and clinicians, together with our <strong>MH</strong>TP partners.<br />

This was a remarkable year for <strong>MH</strong>TP,<br />

with 1171 active research projects<br />

under way. From world-first oncology<br />

trials such as those lead by Dr Ben<br />

Markman and a world-first study in<br />

pre-term infants led by Professor Euan<br />

Wallace – our research offers hope<br />

to many patients and families facing<br />

seriou illness.<br />

The title of this report reflects our<br />

commitment to collaborative research<br />

with our key research partners, the<br />

Hudson Institute of Medical Research<br />

and Monash University.<br />

Clinical trials are a major component of<br />

Monash Health’s research profile and<br />

present an opportunity for consumers<br />

to access the latest technology,<br />

advancements and access to increased<br />

resources in terms of monitoring,<br />

follow up and positive lifestyle<br />

interventions. This is facilitated<br />

through the state-of-the-art Monash<br />

Health Clinical Trials Centre, which<br />

opened in December 2015.<br />

The calibre of our work has been<br />

acknowledged by our funding success,<br />

with more than $15.3 million in<br />

National Health and Medical Research<br />

Council of Australia (NHMRC) funding<br />

awarded to Monash Health and our<br />

<strong>MH</strong>TP partners in 2017. In addition,<br />

we secured more than $20 million in<br />

funding for commercially-sponsored<br />

clinical trials by leading pharmaceutical<br />

and biotechnology companies.<br />

Leadership is a key component of<br />

driving outstanding research, leading<br />

to excellent patient outcomes.<br />

Research leadership is supported by<br />

Professor Erwin Loh, as the Executive<br />

Director for Research and Professor Bill<br />

Sievert, Clinical Research Director and<br />

the Monash Health Research Council,<br />

who represent research across Monash<br />

Health and our partners.<br />

Monash Health is also a major partner<br />

in the Monash Partners Academic<br />

Health Science Centre (MPAHSC), a<br />

group of eight independent, worldclass<br />

providers of health services,<br />

research and education in Melbourne’s<br />

south east. We were pleased to lead<br />

an application to the NHMRC for this<br />

centre to be recognised as one of a<br />

limited number of national Academic<br />

Science Centres. Our research is<br />

reliant on the participation of patients,<br />

volunteers and carers, who dedicate<br />

their time for the benefit of future<br />

healthcare outcomes. We are very<br />

grateful for their contribution. We<br />

would like to thank all of the patients,<br />

volunteers and carers who partner<br />

with us and look forward to our work<br />

contributing to better outcomes for<br />

all. We could not be prouder of our<br />

clinicians and researchers and their<br />

wonderful work of discovery and<br />

innovation.<br />

Andrew Stripp<br />

Chief Executive, Monash Health<br />

Barbara Yeoh, AM<br />

Chair, Board of Directors<br />

06

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!